Biotech · Private company
Sling Therapeutics, Inc.
Track this companyFree. Adds Sling Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- linsitinibPhase 3 · Thyroid Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- linsitinibPhase 3 · Thyroid Eye Disease, TEDClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)PHASE3 · RECRUITING · started Aug 4, 2026ClinicalTrials.gov NCT07753603 · fetched Nov 12, 2026
- Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)PHASE2_PHASE3 · RECRUITING · started Oct 11, 2023ClinicalTrials.gov NCT06112340 · fetched Nov 12, 2026
- A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)PHASE2_PHASE3 · COMPLETED · started Jul 1, 2022ClinicalTrials.gov NCT05276063 · fetched Nov 12, 2026